About HumanTrue
Humans first. Evidence always.
Our point of view
AI makes verification more important, not less.
Clinical trials are built from dense, interdependent specifications interpreted by hundreds of people and systems. When those specifications conflict, automation multiplies the problem. HumanTrue exists to make the source trustworthy, executable, and useful to every downstream team.
True First. Fast Second.
Leadership & Team
- Co-founder & CEO
Joan Severson
Clinical-trial technology executive, computer scientist, and human-factors leader with more than two decades building digital health and research platforms. Joan co-founded Digital Artefacts, later acquired by Clinical ink in 2021, and has served as an NIH grant reviewer for approximately 20 years. Her work spans digital biomarkers, decentralized trials, health literacy, publications, and patented clinical technology.
- Co-founder & CTO
Bill Lynch
Enterprise software entrepreneur and product leader. Bill co-founded Jive Software, which went public in 2011 and was acquired by Aurea in 2017, and later led product and technology work across cloud infrastructure and clinical-trial software. He brings deep experience turning complex enterprise workflows into secure, scalable products.
Our team of designers, software engineers, and industry experts
We are a team of U.S.-based senior software engineers, PhD-level scientists, and clinical trial specialists. Our interdisciplinary team combines deep domain knowledge in neuroscience, AI, and medical research with industry-tested product development and design capabilities.
Advisors
AdvisorLaura Hilty
Laura brings two decades of experience in healthcare technology spanning clinical trial tech and EHR systems. She has held leadership roles in corporate strategy, product management, and partnerships across companies from startup to scale, launching technology products and completing strategic acquisitions along the way.
Laura currently serves as Chief Strategy Officer at IgniteData and is a Principal at HealthX Ventures, a digital healthcare-focused venture capital firm. She previously served as Vice President of Strategy at Advarra and spent over a decade at Forte Research Systems leading product management and strategy.
AdvisorJoe Mather
Joe is a global R&D executive who spent 25 years at Pfizer and AstraZeneca shaping the future of digital health, diagnostics, regulatory strategy, and translational science. As Vice President of Digital Science at Pfizer and Head of R&D at Lucira by Pfizer, he took products from first concept to market clearance and embedded digital endpoints into global clinical programs at scale.
He now advises leading digital medicine programs on regulatory strategy, usability evidence, and trial operationalization, drawing on a career that includes co-directing the AstraZeneca-Tufts Lab for Basic and Translational Neuroscience. Joe works where science, technology, and policy converge, driving data-driven healthcare solutions in partnership with regulators, academic institutions, and industry leaders worldwide.
Recognition
Built around real clinical-trial work.
HumanTrue received Best User Experience (UX) Design for Protocol Review in the 2026 TransCelerate Protocol Review Challenge, recognizing its Schedule of Activities and protocol-review experience.
Read about the awardOur mission
Make clinical research more coherent, accessible, and executable.
We exist to ease the load of the people carrying the weight of clinical research, those who design, run, and support trials every day. By turning complexity into clarity and making critical information accessible when and where it's needed, we empower every stakeholder to do their best work. The result: faster, more efficient trials that bring life-changing solutions to patients sooner.